lucidone and Carcinoma--Pancreatic-Ductal

lucidone has been researched along with Carcinoma--Pancreatic-Ductal* in 1 studies

Other Studies

1 other study(ies) available for lucidone and Carcinoma--Pancreatic-Ductal

Article	Year
Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. Phytotherapy research : PTR, 2022, Volume: 36, Issue:4 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cyclopentanes; HMGB1 Protein; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Signal Transduction	2022

Article

Year

Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells.

Phytotherapy research : PTR, 2022, Volume: 36, Issue:4

Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cyclopentanes; HMGB1 Protein; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Signal Transduction

2022